Page 6 - Flipbook
P. 6
By participating in this learning program,
health care providers can expect to:
• Identify patients with prostate cancer
who would benefit from enhanced
Overall Program treatment options
• Contrast the various treatment options
Learning Objectives for patients with mCSPC
• Describe the emerging data for
diagnostic and treatment options for
patients with mCRPC
• Examine the results from the Canadian
consensus forum and discuss
application to Canadian clinical
practice
mCSPC, metastatic castrate-sensitive prostate cancer; mCRPC, metastatic castrate-resistant prostate cancer
